BTA biota holdings limited
Add to My Watchlist 0.00% ! 57.0¢

From the Daiichi Sankyo annual report:" Phase III clinical...

  1. PortableAlpha
    3,045 Posts.
    clock Created with Sketch.
    12/05/09
    23:04
    Post #: 5127939
    From the Daiichi Sankyo annual report:

    " Phase III clinical trials were completed in Japan for the anti-influenza drug CS-8958. The Company plans to submit an application for regulatory approval during fiscal 2009."

    Note they have a slightly different FY. Sounds like they are still positive on the trial.
    BTA Price at posting: $1.10 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS BPM Acquires High-Grade Forelands Gold Project with Near-Surface Mineralisation
right-arrow Created with Sketch.
NEWS Anson Adds 100 Strategic Claims to Green River Lithium Project
right-arrow Created with Sketch.
NEWS Activeport Secures Network Transformation Contract with Ishan Technologies
right-arrow Created with Sketch.
NEWS Gold Mountain Expands Anomalous Rare Earths Areas at Down Under Project
right-arrow Created with Sketch.
VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
NEWS Modelling Confirms Exceptional Heat Sink Performance for VHD Technology
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.